{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:21:39Z","timestamp":1794360099419,"version":"4.9.0"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"unspecified","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2026,3,26]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Syndromic conditions are frequently associated with congenital heart disease (CHD). Their distribution, recognition and prognostic impact in adults with CHD (ACHD) remain poorly characterised due to limited assessment beyond childhood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analysed 9826 patients with ACHD from a tertiary ACHD centre. Syndromic conditions were identified from clinical records and categorised as chromosomal, single-gene or other syndromes. Clinical characteristics, comorbidities and CHD complexity were compared between syndromic and non-syndromic patients. Multivariable Cox regression was used to evaluate associations with all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 9826 patients, 1069 (10.9%) had a syndromic diagnosis. Marfan syndrome (4.1%) and Down syndrome (3.6%) were the most common, followed by Noonan syndrome (0.7%) and 22q11.2 deletion syndrome (0.7%). Syndromic patients were younger (median 34 vs 39 years), had higher rates of pulmonary arterial hypertension (15% vs 5.9%)\u2009and sleep apnoea (7.4% vs 2.8%), but fewer traditional cardiovascular risk factors. Down syndrome clustered with atrioventricular septal defect and 22q11.2 deletion with conotruncal defects. In Tetralogy of Fallot, 4.3% had 22q11.2 deletion, mostly diagnosed in childhood; among those without prior diagnosis, most were neither clinically suspected nor tested in adulthood, suggesting under-recognition compared with paediatric cohorts. A syndromic diagnosis was independently associated with higher all-cause mortality (HR 2.06, 95%\u2009CI 1.76 to 2.42, p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We present herewith our institutional ACHD data showing that approximately 1 in 10 patients had a syndromic condition, which was clinically relevant in many respects, cardiovascular or other, including overall mortality. We submit that improved recognition and expanded access to genetic screening may provide additional information relevant to risk stratification and long-term outcome in this growing patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2026-003971","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:35:11Z","timestamp":1776864911000},"page":"e003971","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Distribution, recognition and clinical implications of syndromic conditions in adults with congenital heart disease"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-5617","authenticated-orcid":false,"given":"Masahiko","family":"Umei","sequence":"first","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard Paul","family":"Diller","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"Adult Congenital and Valvular Heart Disease Center, Department of Cardiology and Angiology, University Hospital Munster Department of Cardiology III Congenital Heart Defects and Valve Diseases, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8754-8156","authenticated-orcid":false,"given":"Margarita","family":"Brida","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan-Chen","family":"Aw","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Critical Care, Royal Brompton Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hoschtitzky","sequence":"additional","affiliation":[{"name":"Department of Congenital Cardiac Surgery, Royal Brompton and Harefield Hospitals, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Kempny","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Gatzoulis","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"2026042206350628000_13.1.e003971.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01886-7"},{"key":"2026042206350628000_13.1.e003971.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa701"},{"key":"2026042206350628000_13.1.e003971.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017202"},{"key":"2026042206350628000_13.1.e003971.4","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2017-311997"},{"key":"2026042206350628000_13.1.e003971.5","article-title":"Aortic growth rates in a Swedish cohort of women with Turner syndrome","volume":"15","author":"Thunstr\u00f6m","year":"2024","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"2026042206350628000_13.1.e003971.6","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2023-323126"},{"key":"2026042206350628000_13.1.e003971.7","article-title":"Skeletal system in adult congenital heart disease","volume":"13","author":"Alonso-Gonzalez","year":"2023","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"2026042206350628000_13.1.e003971.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2008.11.005"},{"key":"2026042206350628000_13.1.e003971.9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.tcm.2016.04.004","article-title":"Extra-cardiac manifestations of adult congenital heart disease","volume":"26","author":"Gaeta","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"2026042206350628000_13.1.e003971.10","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000682"},{"key":"2026042206350628000_13.1.e003971.11","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.21037\/tp-21-297","article-title":"Genetics of congenital heart disease: a narrative review of recent advances and clinical implications","volume":"10","author":"Yasuhara","year":"2021","journal-title":"Transl Pediatr"},{"key":"2026042206350628000_13.1.e003971.12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tcm.2021.04.011","article-title":"A new era of genetic testing in congenital heart disease: A review","volume":"32","author":"Morrish","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"2026042206350628000_13.1.e003971.13","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1412806","article-title":"Genetic investigation and diagnosis in adults with congenital heart disease with or without structural or neurodevelopmental comorbidity: a retrospective chart review","volume":"15","author":"Edwards","year":"2024","journal-title":"Front Genet"},{"key":"2026042206350628000_13.1.e003971.14","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1398887","article-title":"Current approach to genetic testing and genetic evaluation referrals for adults with congenital heart disease","volume":"15","author":"Oehlman","year":"2024","journal-title":"Front Genet"},{"key":"2026042206350628000_13.1.e003971.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01272-4"},{"key":"2026042206350628000_13.1.e003971.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.02.118"},{"key":"2026042206350628000_13.1.e003971.17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00125817-200101000-00012","article-title":"Tetralogy of Fallot associated with chromosome 22q11.2 deletion in adolescents and young adults","volume":"3","author":"Momma","year":"2001","journal-title":"Genet Med"},{"key":"2026042206350628000_13.1.e003971.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00259-9"},{"key":"2026042206350628000_13.1.e003971.19","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2009.182642"},{"key":"2026042206350628000_13.1.e003971.20","first-page":"1233","article-title":"Risk factors for excess mortality in adults with congenital heart diseases","volume":"38","author":"Oliver","year":"2017","journal-title":"Eur Heart J"},{"key":"2026042206350628000_13.1.e003971.21","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000535"},{"key":"2026042206350628000_13.1.e003971.22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10020314","article-title":"Acquired Comorbidities in Adults with Congenital Heart Disease: An Analysis of the German National Register for Congenital Heart Defects","volume":"10","author":"Maurer","year":"2021","journal-title":"J Clin Med"},{"key":"2026042206350628000_13.1.e003971.23","first-page":"1091","article-title":"Impact of a 22q11.2 Microdeletion on Adult All-Cause Mortality in Tetralogy of Fallot Patients","volume":"36","author":"van Mil","year":"2020","journal-title":"Can J Cardiol"},{"key":"2026042206350628000_13.1.e003971.24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2020.02.064","article-title":"22q11.2 deletion syndrome is associated with increased mortality in adults with tetralogy of Fallot and pulmonary atresia with ventricular septal defect","volume":"306","author":"Kauw","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026042206350628000_13.1.e003971.25","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321085"},{"key":"2026042206350628000_13.1.e003971.26","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41436-019-0509-y","article-title":"All-cause mortality and survival in adults with 22q11.2 deletion syndrome","volume":"21","author":"Van","year":"2019","journal-title":"Genet Med"},{"key":"2026042206350628000_13.1.e003971.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.11.012"},{"key":"2026042206350628000_13.1.e003971.28","first-page":"100108","article-title":"Establishing the diagnosis of 22q11.2 microdeletion syndrome in congenital heart disease is now an imperative","volume":"3","author":"Arvanitaki","year":"2021","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"2026042206350628000_13.1.e003971.29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijcard.2016.06.292","article-title":"A time for greater investment into care for pregnancy and heart disease","volume":"221","author":"Cauldwell","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026042206350628000_13.1.e003971.30","article-title":"Cognitive impairment in adult CHD survivors: A pilot study","volume":"6","author":"Rodriguez","year":"2021","journal-title":"Int J Cardiol Congenit Heart Dis"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2026-003971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:35:13Z","timestamp":1776864913000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2026-003971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,22]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/openhrt-2026-003971"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2026-003971","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}